halofuginone has been researched along with Graft-Versus-Host Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Cheng, H; Pan, B; Song, G; Sun, Y; Wu, Y; Xu, K; Zeng, L; Zhang, Y | 1 |
| Bian, YP; Cheng, H; Pan, B; Song, GL; Xia, DD; Xu, KL; Yao, Y; Zeng, LY | 1 |
| Chen, W; Cheng, H; Li, Z; Pan, B; Song, G; Tian, J; Xu, K; Zeng, L | 2 |
| Nagler, A; Pines, M; Snyder, D; Yarkoni, S | 1 |
| Knopov, V; Levi-Schaffer, F; Nagler, A; Pines, M; Slavin, S | 1 |
| Genina, O; Halevy, O; Levi-Schaffer, F; Nagler, A; Pines, M | 1 |
| Nagler, A; Pines, M | 1 |
1 review(s) available for halofuginone and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma.
Topics: Administration, Cutaneous; Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Collagen Type I; Fibrosis; Graft vs Host Disease; Humans; Mice; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Scleroderma, Systemic | 2003 |
7 other study(ies) available for halofuginone and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice.
Topics: Acute Disease; Animals; Disease Progression; Graft vs Host Disease; Interferon-gamma; Interleukin-17; Lymphocyte Count; Mice, Inbred BALB C; Mice, Inbred C57BL; Organ Specificity; Piperidines; Quinazolinones; Th1 Cells; Th17 Cells | 2014 |
[Significance of Th1/Th17 Imbalance in Mice with Acute Graft-versus-Host Disease].
Topics: Animals; Disease Models, Animal; Graft vs Host Disease; Interferon-gamma; Interleukin-17; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Piperidines; Quinazolinones; Th1 Cells; Th17 Cells | 2015 |
TH17 cells are critical for skin-specific pathological injury in acute graft-versus-host disease.
Topics: Acute Disease; Animals; Bone Marrow Transplantation; Cell Differentiation; Cell Separation; Cells, Cultured; Disease Models, Animal; Female; Flow Cytometry; Graft vs Host Disease; Inflammation Mediators; Interleukin-17; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Piperidines; Quinazolinones; Skin; Th1 Cells; Th17 Cells; Time Factors | 2012 |
Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation.
Topics: Angiogenesis Inhibitors; Animals; Bone Marrow Transplantation; Cell Differentiation; Chronic Disease; Cytokines; Female; Graft vs Host Disease; Male; Mice; Mice, Inbred BALB C; Piperidines; Quinazolinones; Skin Diseases; Th17 Cells; Time Factors; Transplantation, Homologous | 2012 |
Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone.
Topics: Animals; Collagen; Disease Models, Animal; Fibrosis; Graft vs Host Disease; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Osmolar Concentration; Piperidines; Quinazolines; Quinazolinones; Scleroderma, Localized; Skin | 1996 |
Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone.
Topics: Adult; Coccidiostats; Collagen; Dose-Response Relationship, Drug; Female; Fibroblasts; Graft vs Host Disease; Humans; Middle Aged; Piperidines; Quinazolines; Quinazolinones; Time Factors | 1996 |
Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis.
Topics: Administration, Topical; Adult; Animals; Collagen; Gene Expression; Graft vs Host Disease; Humans; Male; Neck; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rabbits; Range of Motion, Articular; Sclerosis; Skin; Skin Transplantation | 1999 |